Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll New approaches to the treatment of human herpesvirus 8-associated disease Casper CRev Med Virol 2008[Sep]; 18 (5): 321-9Human herpesvirus 8 (HHV-8, also known as Kaposi sarcoma-associated herpesvirus or KSHV) is the etiologic agent of Kaposi sarcoma (KS) and primary effusion lymphoma (PEL), as well as many cases of Castleman disease. Despite significant advances in understanding the biology and natural history of these diseases, current treatment options have important limitations, and strategies to prevent their development in high-risk individuals are lacking. This article reviews the scope of HHV-8-associated disease, as well as the efficacy of current treatment options. Finally, novel approaches to treatment and prevention are described, including antiviral agents, targeted molecular therapy and a combination of these modalities.|Antiviral Agents/therapeutic use[MESH]|Castleman Disease/drug therapy/immunology/pathology/virology[MESH]|Clinical Trials as Topic[MESH]|Ganciclovir/analogs & derivatives/therapeutic use[MESH]|Herpesviridae Infections/*classification/drug therapy/epidemiology/*therapy/virology[MESH]|Herpesvirus 8, Human/*drug effects[MESH]|Humans[MESH]|Lymphoma, Primary Effusion/drug therapy/epidemiology/pathology[MESH]|Sarcoma, Kaposi/drug therapy/epidemiology/pathology[MESH]|Valganciclovir[MESH] |